Relief Therapeutics Holding SA (ETR:RLF) | Finanzwire

Basculer en Français

9529	Companies
187479	Keywords
119514	Articles
100217	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

BRIEF

published on 12/15/2025 at 07:05, 12 hours 6 minutes ago

Relief Therapeutics and NeuroX Finalize Merger to Form MindMaze Therapeutics

SIX Swiss Exchange Business Merger Neurological Diseases MindMaze Therapeutics Digital Treatments
PRESS RELEASE

published on 12/15/2025 at 07:00, 12 hours 11 minutes ago

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
Relief Therapeutics and NeuroX complete business combination forming MindMaze Therapeutics. Newly integrated entity aims to redefine neurological care with digital treatments and AI-powered solutions

Business Combination Relief Therapeutics NeuroX MindMaze Therapeutics Neurological Care
BRIEF

published on 11/25/2025 at 07:05, 20 days 12 hours ago

Relief Therapeutics and NeuroX Present Financial Outlook for Merger

EBITDA Margin Financial Outlook Relief Therapeutics NeuroX Merger Digital Neurotherapeutics
PRESS RELEASE

published on 11/25/2025 at 07:00, 20 days 12 hours ago

Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics and NeuroX reveal joint presentation and financial outlook in anticipation of business combination. Financial guidance includes revenue projections and EBITDA margin targets

Business Combination Financial Outlook Relief Therapeutics Press Conference NeuroX
BRIEF

published on 11/14/2025 at 18:25, 1 month 1 day ago

Relief Therapeutics Shareholders Approve Merger with NeuroX

Leadership Changes Shareholder Approval Capital Increase Relief Therapeutics NeuroX Merger
PRESS RELEASE

published on 11/14/2025 at 18:20, 1 month 1 day ago

Relief Therapeutics Shareholders Approve Business Combination with NeuroX
Relief Therapeutics shareholders approve business combination with NeuroX, creating a digital neurotherapeutics company. New board members elected. Business combination expected to close in December 2025

Shareholders Business Combination Relief Therapeutics NeuroX Digital Neurotherapeutics
BRIEF

published on 10/29/2025 at 07:05, 1 month 17 days ago

Relief Therapeutics Reports Positive Outcomes in RLF-OD032 Study

FDA Approval RLF-OD032 Phenylketonuria Treatment Bioequivalence Study Sapropterin Dihydrochloride
PRESS RELEASE

published on 10/29/2025 at 07:00, 1 month 17 days ago

Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032
Relief Therapeutics announces positive results from pivotal bioequivalence study of RLF-OD032, demonstrating bioequivalence to KUVAN®, supporting NDA submission in early 2026

FDA Approval Relief Therapeutics RLF-OD032 Bioequivalence Study PKU Treatment
BRIEF

published on 10/24/2025 at 07:04, 1 month 22 days ago

Relief Therapeutics Schedules Extraordinary General Meeting for Business Merger

Business Combination Extraordinary General Meeting Relief Therapeutics MindMaze Therapeutics NeuroX Group
PRESS RELEASE

published on 10/24/2025 at 06:59, 1 month 22 days ago

Relief Therapeutics Convenes Extraordinary General Meeting
Relief Therapeutics announces Extraordinary General Meeting to seek shareholder approval for business combination with NeuroX Group SA

EGM Business Combination Extraordinary General Meeting Relief Therapeutics NeuroX Group SA

1 2 ... 6

Accesswire

Published on 12/15/2025 at 18:15, 56 minutes ago

Athena Gold Closes Second Tranche of Non-brokered Private Placement and Increases Offering Due to Strong Demand
Published on 12/15/2025 at 16:35, 2 hours 36 minutes ago

Stillwater Critical Minerals Announces Upsize of Bought Deal LIFE Private Placement for Gross Proceeds of C$15 Million
Published on 12/15/2025 at 15:00, 4 hours 11 minutes ago

Kingfisher Reports Annual General Meeting Voting Results
Published on 12/15/2025 at 15:00, 4 hours 11 minutes ago

Jaguar Health Announces Abstract Submission for Preliminary Data from US Investigator-Initiated Trial of Crofelemer in Adult Patients with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Published on 12/15/2025 at 14:30, 4 hours 41 minutes ago

Unusual Machines Congratulates Customers Selected for the Army's PBAS Tranche 1.1, Including Envision Technology and Strategic Logix

View all ACCESSWIRE

EQS Group

Published on 12/15/2025 at 18:15, 56 minutes ago

Results of EQT’s mandatory simplified cash tender offer for Waga Energy’s remaining shares
Published on 12/15/2025 at 18:07, 1 hour 3 minutes ago

POS-Transaction in Own Shares
Published on 12/15/2025 at 18:00, 1 hour 10 minutes ago

LIGHTON: Adjustment of ARR target for FY 2025
Published on 12/15/2025 at 17:45, 1 hour 25 minutes ago

EQS-Adhoc: Airbus SE: Airbus reports share buybacks for week starting 8 December 2025
Published on 12/15/2025 at 17:38, 1 hour 32 minutes ago

Stabilus SE approves share buyback program with a volume of up to €20 million

Les Echos

Published on 12/15/2025 at 18:30, 41 minutes ago

MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 1 hour 6 minutes ago

Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 1 hour 25 minutes ago

ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
Published on 12/15/2025 at 17:40, 1 hour 31 minutes ago

LISI joins the SBF 120 and CAC Mid 60 indices
Published on 12/15/2025 at 17:35, 1 hour 36 minutes ago

DISCLOSURE OF TRANSACTIONS IN OWN SHARES FROM DECEMBER 8 TO DECEMBER 12, 2025

View all LES ECHOS COMFI WIRE